SHPG Dividend History & Description — Shire Plc (Jersey)
Shire is a holding company. Through its subsidiaries, Co. operates as a biotechnology company focused on serving people with rare diseases and other conditions. Co.'s portfolio covers seven therapeutic areas: Immunology, Hematology, Neuroscience, Internal Medicine (IM), Genetic Diseases, Oncology, and Ophthalmics. Some of Co.'s marketed products include GAMMAGARD, HYQVIA and CINRYZE for Immunology, ADVATE/ADYNOVATE, VONVENDI and FEIBA for Hematology, VYVANSE and ADDERALL XR for Neuroscience, LIALDA/MEZAVANT and PENTASA for IM, ELAPRASE and REPLAGAL for Genetic Diseases, ONCASPAR and ONYVIDE for Oncology and XIIDRA for Ophthalmics. When considering the Shire Plc (Jersey) stock dividend history, we have taken known splits into account, such that the SHPG dividend history is presented on a split-adjusted ("apples to apples") basis. Shire Plc (Jersey) dividend history is presented both in graphical/chart form, and as a SHPG dividend history data table along the right-hand column.